1 Market Overview

1.1 Product Overview and Scope of Cell and Gene Therapy Manufacturing QC

1.2 Classification of Cell and Gene Therapy Manufacturing QC by Type

1.2.1 Overview: Global Cell and Gene Therapy Manufacturing QC Market Size by Type: 2020 Versus 2021 Versus 2026

1.2.2 Global Cell and Gene Therapy Manufacturing QC Revenue Market Share by Type in 2020

1.2.3 Safety Testing

1.2.4 Purity Testing

1.2.5 Potency Testing

1.2.6 Identity Testing

1.2.7 Stability Testing

1.3 Global Cell and Gene Therapy Manufacturing QC Market by Application

1.3.1 Overview: Global Cell and Gene Therapy Manufacturing QC Market Size by Application: 2020 Versus 2021 Versus 2026

1.3.2 Precision Therapy

1.3.3 Biological Research

1.4 Global Cell and Gene Therapy Manufacturing QC Market Size & Forecast

1.5 Global Cell and Gene Therapy Manufacturing QC Market Size and Forecast by Region

1.5.1 Global Cell and Gene Therapy Manufacturing QC Market Size by Region: 2016 VS 2021 VS 2026

1.5.2 Global Cell and Gene Therapy Manufacturing QC Market Size by Region, (2016-2021)

1.5.3 North America Cell and Gene Therapy Manufacturing QC Market Size and Prospect (2016-2026)

1.5.4 Europe Cell and Gene Therapy Manufacturing QC Market Size and Prospect (2016-2026)

1.5.5 Asia-Pacific Cell and Gene Therapy Manufacturing QC Market Size and Prospect (2016-2026)

1.5.6 South America Cell and Gene Therapy Manufacturing QC Market Size and Prospect (2016-2026)

1.5.7 Middle East and Africa Cell and Gene Therapy Manufacturing QC Market Size and Prospect (2016-2026)

1.6 Market Drivers, Restraints and Trends

1.6.1 Cell and Gene Therapy Manufacturing QC Market Drivers

1.6.2 Cell and Gene Therapy Manufacturing QC Market Restraints

1.6.3 Cell and Gene Therapy Manufacturing QC Trends Analysis

2 Company Profiles

2.1 Bio-Techne Corporation

2.1.1 Bio-Techne Corporation Details

2.1.2 Bio-Techne Corporation Major Business

2.1.3 Bio-Techne Corporation Cell and Gene Therapy Manufacturing QC Product and Solutions

2.1.4 Bio-Techne Corporation Cell and Gene Therapy Manufacturing QC Revenue, Gross Margin and Market Share (2019-2021)

2.1.5 Bio-Techne Corporation Recent Developments and Future Plans

2.2 BioMerieux SA

2.2.1 BioMerieux SA Details

2.2.2 BioMerieux SA Major Business

2.2.3 BioMerieux SA Cell and Gene Therapy Manufacturing QC Product and Solutions

2.2.4 BioMerieux SA Cell and Gene Therapy Manufacturing QC Revenue, Gross Margin and Market Share (2019-2021)

2.2.5 BioMerieux SA Recent Developments and Future Plans

2.3 Catalent, Inc.

2.3.1 Catalent, Inc. Details

2.3.2 Catalent, Inc. Major Business

2.3.3 Catalent, Inc. Cell and Gene Therapy Manufacturing QC Product and Solutions

2.3.4 Catalent, Inc. Cell and Gene Therapy Manufacturing QC Revenue, Gross Margin and Market Share (2019-2021)

2.3.5 Catalent, Inc. Recent Developments and Future Plans

2.4 Charles River Laboratories International Inc.

2.4.1 Charles River Laboratories International Inc. Details

2.4.2 Charles River Laboratories International Inc. Major Business

2.4.3 Charles River Laboratories International Inc. Cell and Gene Therapy Manufacturing QC Product and Solutions

2.4.4 Charles River Laboratories International Inc. Cell and Gene Therapy Manufacturing QC Revenue, Gross Margin and Market Share (2019-2021)

2.4.5 Charles River Laboratories International Inc. Recent Developments and Future Plans

2.5 Eurofins Scientific SE

2.5.1 Eurofins Scientific SE Details

2.5.2 Eurofins Scientific SE Major Business

2.5.3 Eurofins Scientific SE Cell and Gene Therapy Manufacturing QC Product and Solutions

2.5.4 Eurofins Scientific SE Cell and Gene Therapy Manufacturing QC Revenue, Gross Margin and Market Share (2019-2021)

2.5.5 Eurofins Scientific SE Recent Developments and Future Plans

2.6 F. Hoffmann-La Roche Ltd

2.6.1 F. Hoffmann-La Roche Ltd Details

2.6.2 F. Hoffmann-La Roche Ltd Major Business

2.6.3 F. Hoffmann-La Roche Ltd Cell and Gene Therapy Manufacturing QC Product and Solutions

2.6.4 F. Hoffmann-La Roche Ltd Cell and Gene Therapy Manufacturing QC Revenue, Gross Margin and Market Share (2019-2021)

2.6.5 F. Hoffmann-La Roche Ltd Recent Developments and Future Plans

2.7 Intertek Group plc

2.7.1 Intertek Group plc Details

2.7.2 Intertek Group plc Major Business

2.7.3 Intertek Group plc Cell and Gene Therapy Manufacturing QC Product and Solutions

2.7.4 Intertek Group plc Cell and Gene Therapy Manufacturing QC Revenue, Gross Margin and Market Share (2019-2021)

2.7.5 Intertek Group plc Recent Developments and Future Plans

2.8 Lonza Group AG

2.8.1 Lonza Group AG Details

2.8.2 Lonza Group AG Major Business

2.8.3 Lonza Group AG Cell and Gene Therapy Manufacturing QC Product and Solutions

2.8.4 Lonza Group AG Cell and Gene Therapy Manufacturing QC Revenue, Gross Margin and Market Share (2019-2021)

2.8.5 Lonza Group AG Recent Developments and Future Plans

2.9 Merck KGaA

2.9.1 Merck KGaA Details

2.9.2 Merck KGaA Major Business

2.9.3 Merck KGaA Cell and Gene Therapy Manufacturing QC Product and Solutions

2.9.4 Merck KGaA Cell and Gene Therapy Manufacturing QC Revenue, Gross Margin and Market Share (2019-2021)

2.9.5 Merck KGaA Recent Developments and Future Plans

2.10 Sartorius AG

2.10.1 Sartorius AG Details

2.10.2 Sartorius AG Major Business

2.10.3 Sartorius AG Cell and Gene Therapy Manufacturing QC Product and Solutions

2.10.4 Sartorius AG Cell and Gene Therapy Manufacturing QC Revenue, Gross Margin and Market Share (2019-2021)

2.10.5 Sartorius AG Recent Developments and Future Plans

2.11 SGS S.A.

2.11.1 SGS S.A. Details

2.11.2 SGS S.A. Major Business

2.11.3 SGS S.A. Cell and Gene Therapy Manufacturing QC Product and Solutions

2.11.4 SGS S.A. Cell and Gene Therapy Manufacturing QC Revenue, Gross Margin and Market Share (2019-2021)

2.11.5 SGS S.A. Recent Developments and Future Plans

2.12 Sistemic Scotland Limited

2.12.1 Sistemic Scotland Limited Details

2.12.2 Sistemic Scotland Limited Major Business

2.12.3 Sistemic Scotland Limited Cell and Gene Therapy Manufacturing QC Product and Solutions

2.12.4 Sistemic Scotland Limited Cell and Gene Therapy Manufacturing QC Revenue, Gross Margin and Market Share (2019-2021)

2.12.5 Sistemic Scotland Limited Recent Developments and Future Plans

2.13 Thermo Fisher Scientific Inc.

2.13.1 Thermo Fisher Scientific Inc. Details

2.13.2 Thermo Fisher Scientific Inc. Major Business

2.13.3 Thermo Fisher Scientific Inc. Cell and Gene Therapy Manufacturing QC Product and Solutions

2.13.4 Thermo Fisher Scientific Inc. Cell and Gene Therapy Manufacturing QC Revenue, Gross Margin and Market Share (2019-2021)

2.13.5 Thermo Fisher Scientific Inc. Recent Developments and Future Plans

2.14 Vigene Biosciences, Inc.

2.14.1 Vigene Biosciences, Inc. Details

2.14.2 Vigene Biosciences, Inc. Major Business

2.14.3 Vigene Biosciences, Inc. Cell and Gene Therapy Manufacturing QC Product and Solutions

2.14.4 Vigene Biosciences, Inc. Cell and Gene Therapy Manufacturing QC Revenue, Gross Margin and Market Share (2019-2021)

2.14.5 Vigene Biosciences, Inc. Recent Developments and Future Plans

2.15 WuXi AppTec

2.15.1 WuXi AppTec Details

2.15.2 WuXi AppTec Major Business

2.15.3 WuXi AppTec Cell and Gene Therapy Manufacturing QC Product and Solutions

2.15.4 WuXi AppTec Cell and Gene Therapy Manufacturing QC Revenue, Gross Margin and Market Share (2019-2021)

2.15.5 WuXi AppTec Recent Developments and Future Plans

3 Market Competition, by Players

3.1 Global Cell and Gene Therapy Manufacturing QC Revenue and Share by Players (2019-2021)

3.2 Market Concentration Rate

3.2.1 Top 3 Cell and Gene Therapy Manufacturing QC Players Market Share

3.2.2 Top 10 Cell and Gene Therapy Manufacturing QC Players Market Share

3.2.3 Market Competition Trend

3.3 Cell and Gene Therapy Manufacturing QC Players Head Office, Products and Services Provided

3.4 Mergers & Acquisitions

3.5 New Entrants and Expansion Plans

4 Market Size Segment by Type

4.1 Global Cell and Gene Therapy Manufacturing QC Revenue and Market Share by Type (2016-2021)

4.2 Global Cell and Gene Therapy Manufacturing QC Market Forecast by Type (2021-2026)

5 Market Size Segment by Application

5.1 Global Cell and Gene Therapy Manufacturing QC Revenue Market Share by Application (2016-2021)

5.2 Cell and Gene Therapy Manufacturing QC Market Forecast by Application (2021-2026)

6 North America by Country, by Type, and by Application

6.1 North America Cell and Gene Therapy Manufacturing QC Revenue by Type (2016-2026)

6.2 North America Cell and Gene Therapy Manufacturing QC Revenue by Application (2016-2026)

6.3 North America Cell and Gene Therapy Manufacturing QC Market Size by Country

6.3.1 North America Cell and Gene Therapy Manufacturing QC Revenue by Country (2016-2026)

6.3.2 United States Cell and Gene Therapy Manufacturing QC Market Size and Forecast (2016-2026)

6.3.3 Canada Cell and Gene Therapy Manufacturing QC Market Size and Forecast (2016-2026)

6.3.4 Mexico Cell and Gene Therapy Manufacturing QC Market Size and Forecast (2016-2026)

7 Europe by Country, by Type, and by Application

7.1 Europe Cell and Gene Therapy Manufacturing QC Revenue by Type (2016-2026)

7.2 Europe Cell and Gene Therapy Manufacturing QC Revenue by Application (2016-2026)

7.3 Europe Cell and Gene Therapy Manufacturing QC Market Size by Country

7.3.1 Europe Cell and Gene Therapy Manufacturing QC Revenue by Country (2016-2026)

7.3.2 Germany Cell and Gene Therapy Manufacturing QC Market Size and Forecast (2016-2026)

7.3.3 France Cell and Gene Therapy Manufacturing QC Market Size and Forecast (2016-2026)

7.3.4 United Kingdom Cell and Gene Therapy Manufacturing QC Market Size and Forecast (2016-2026)

7.3.5 Russia Cell and Gene Therapy Manufacturing QC Market Size and Forecast (2016-2026)

7.3.6 Italy Cell and Gene Therapy Manufacturing QC Market Size and Forecast (2016-2026)

8 Asia-Pacific by Region, by Type, and by Application

8.1 Asia-Pacific Cell and Gene Therapy Manufacturing QC Revenue by Type (2016-2026)

8.2 Asia-Pacific Cell and Gene Therapy Manufacturing QC Revenue by Application (2016-2026)

8.3 Asia-Pacific Cell and Gene Therapy Manufacturing QC Market Size by Region

8.3.1 Asia-Pacific Cell and Gene Therapy Manufacturing QC Revenue by Region (2016-2026)

8.3.2 China Cell and Gene Therapy Manufacturing QC Market Size and Forecast (2016-2026)

8.3.3 Japan Cell and Gene Therapy Manufacturing QC Market Size and Forecast (2016-2026)

8.3.4 South Korea Cell and Gene Therapy Manufacturing QC Market Size and Forecast (2016-2026)

8.3.5 India Cell and Gene Therapy Manufacturing QC Market Size and Forecast (2016-2026)

8.3.6 Southeast Asia Cell and Gene Therapy Manufacturing QC Market Size and Forecast (2016-2026)

8.3.7 Australia Cell and Gene Therapy Manufacturing QC Market Size and Forecast (2016-2026)

9 South America by Country, by Type, and by Application

9.1 South America Cell and Gene Therapy Manufacturing QC Revenue by Type (2016-2026)

9.2 South America Cell and Gene Therapy Manufacturing QC Revenue by Application (2016-2026)

9.3 South America Cell and Gene Therapy Manufacturing QC Market Size by Country

9.3.1 South America Cell and Gene Therapy Manufacturing QC Revenue by Country (2016-2026)

9.3.2 Brazil Cell and Gene Therapy Manufacturing QC Market Size and Forecast (2016-2026)

9.3.3 Argentina Cell and Gene Therapy Manufacturing QC Market Size and Forecast (2016-2026)

10 Middle East & Africa by Country, by Type, and by Application

10.1 Middle East & Africa Cell and Gene Therapy Manufacturing QC Revenue by Type (2016-2026)

10.2 Middle East & Africa Cell and Gene Therapy Manufacturing QC Revenue by Application (2016-2026)

10.3 Middle East & Africa Cell and Gene Therapy Manufacturing QC Market Size by Country

10.3.1 Middle East & Africa Cell and Gene Therapy Manufacturing QC Revenue by Country (2016-2026)

10.3.2 Turkey Cell and Gene Therapy Manufacturing QC Market Size and Forecast (2016-2026)

10.3.3 Saudi Arabia Cell and Gene Therapy Manufacturing QC Market Size and Forecast (2016-2026)

10.3.4 UAE Cell and Gene Therapy Manufacturing QC Market Size and Forecast (2016-2026)

11 Research Findings and Conclusion

12 Appendix

12.1 Methodology

12.2 Research Process and Data Source

12.3 Disclaimer

List of Tables

Table 1. Global Cell and Gene Therapy Manufacturing QC Revenue by Type, (USD Million), 2020 VS 2021 VS 2026

Table 2. Global Cell and Gene Therapy Manufacturing QC Revenue by Application, (USD Million), 2020 VS 2021 VS 2026

Table 3. Global Market Cell and Gene Therapy Manufacturing QC Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)

Table 4. Global Cell and Gene Therapy Manufacturing QC Revenue (USD Million) by Region (2016-2021)

Table 5. Global Cell and Gene Therapy Manufacturing QC Revenue Market Share by Region (2021-2026)

Table 6. Bio-Techne Corporation Corporate Information, Head Office, and Major Competitors

Table 7. Bio-Techne Corporation Major Business

Table 8. Bio-Techne Corporation Cell and Gene Therapy Manufacturing QC Product and Solutions

Table 9. Bio-Techne Corporation Cell and Gene Therapy Manufacturing QC Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 10. BioMerieux SA Corporate Information, Head Office, and Major Competitors

Table 11. BioMerieux SA Major Business

Table 12. BioMerieux SA Cell and Gene Therapy Manufacturing QC Product and Solutions

Table 13. BioMerieux SA Cell and Gene Therapy Manufacturing QC Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 14. Catalent, Inc. Corporate Information, Head Office, and Major Competitors

Table 15. Catalent, Inc. Major Business

Table 16. Catalent, Inc. Cell and Gene Therapy Manufacturing QC Product and Solutions

Table 17. Catalent, Inc. Cell and Gene Therapy Manufacturing QC Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 18. Charles River Laboratories International Inc. Corporate Information, Head Office, and Major Competitors

Table 19. Charles River Laboratories International Inc. Major Business

Table 20. Charles River Laboratories International Inc. Cell and Gene Therapy Manufacturing QC Product and Solutions

Table 21. Charles River Laboratories International Inc. Cell and Gene Therapy Manufacturing QC Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 22. Eurofins Scientific SE Corporate Information, Head Office, and Major Competitors

Table 23. Eurofins Scientific SE Major Business

Table 24. Eurofins Scientific SE Cell and Gene Therapy Manufacturing QC Product and Solutions

Table 25. Eurofins Scientific SE Cell and Gene Therapy Manufacturing QC Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 26. F. Hoffmann-La Roche Ltd Corporate Information, Head Office, and Major Competitors

Table 27. F. Hoffmann-La Roche Ltd Major Business

Table 28. F. Hoffmann-La Roche Ltd Cell and Gene Therapy Manufacturing QC Product and Solutions

Table 29. F. Hoffmann-La Roche Ltd Cell and Gene Therapy Manufacturing QC Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 30. Intertek Group plc Corporate Information, Head Office, and Major Competitors

Table 31. Intertek Group plc Major Business

Table 32. Intertek Group plc Cell and Gene Therapy Manufacturing QC Product and Solutions

Table 33. Intertek Group plc Cell and Gene Therapy Manufacturing QC Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 34. Lonza Group AG Corporate Information, Head Office, and Major Competitors

Table 35. Lonza Group AG Major Business

Table 36. Lonza Group AG Cell and Gene Therapy Manufacturing QC Product and Solutions

Table 37. Lonza Group AG Cell and Gene Therapy Manufacturing QC Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 38. Merck KGaA Corporate Information, Head Office, and Major Competitors

Table 39. Merck KGaA Major Business

Table 40. Merck KGaA Cell and Gene Therapy Manufacturing QC Product and Solutions

Table 41. Merck KGaA Cell and Gene Therapy Manufacturing QC Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 42. Sartorius AG Corporate Information, Head Office, and Major Competitors

Table 43. Sartorius AG Major Business

Table 44. Sartorius AG Cell and Gene Therapy Manufacturing QC Product and Solutions

Table 45. Sartorius AG Cell and Gene Therapy Manufacturing QC Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 46. SGS S.A. Corporate Information, Head Office, and Major Competitors

Table 47. SGS S.A. Major Business

Table 48. SGS S.A. Cell and Gene Therapy Manufacturing QC Product and Solutions

Table 49. SGS S.A. Cell and Gene Therapy Manufacturing QC Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 50. Sistemic Scotland Limited Corporate Information, Head Office, and Major Competitors

Table 51. Sistemic Scotland Limited Major Business

Table 52. Sistemic Scotland Limited Cell and Gene Therapy Manufacturing QC Product and Solutions

Table 53. Sistemic Scotland Limited Cell and Gene Therapy Manufacturing QC Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 54. Thermo Fisher Scientific Inc. Corporate Information, Head Office, and Major Competitors

Table 55. Thermo Fisher Scientific Inc. Major Business

Table 56. Thermo Fisher Scientific Inc. Cell and Gene Therapy Manufacturing QC Product and Solutions

Table 57. Thermo Fisher Scientific Inc. Cell and Gene Therapy Manufacturing QC Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 58. Vigene Biosciences, Inc. Corporate Information, Head Office, and Major Competitors

Table 59. Vigene Biosciences, Inc. Major Business

Table 60. Vigene Biosciences, Inc. Cell and Gene Therapy Manufacturing QC Product and Solutions

Table 61. Vigene Biosciences, Inc. Cell and Gene Therapy Manufacturing QC Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 62. WuXi AppTec Corporate Information, Head Office, and Major Competitors

Table 63. WuXi AppTec Major Business

Table 64. WuXi AppTec Cell and Gene Therapy Manufacturing QC Product and Solutions

Table 65. WuXi AppTec Cell and Gene Therapy Manufacturing QC Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 66. Global Cell and Gene Therapy Manufacturing QC Revenue (USD Million) by Players (2019-2021)

Table 67. Global Cell and Gene Therapy Manufacturing QC Revenue Share by Players (2019-2021)

Table 68. Breakdown of Cell and Gene Therapy Manufacturing QC by Company Type (Tier 1, Tier 2 and Tier 3)

Table 69. Cell and Gene Therapy Manufacturing QC Players Head Office, Products and Services Provided

Table 70. Cell and Gene Therapy Manufacturing QC Mergers & Acquisitions in the Past Five Years

Table 71. Cell and Gene Therapy Manufacturing QC New Entrants and Expansion Plans

Table 72. Global Cell and Gene Therapy Manufacturing QC Revenue (USD Million) by Type (2016-2021)

Table 73. Global Cell and Gene Therapy Manufacturing QC Revenue Share by Type (2016-2021)

Table 74. Global Cell and Gene Therapy Manufacturing QC Revenue Forecast by Type (2021-2026)

Table 75. Global Cell and Gene Therapy Manufacturing QC Revenue by Application (2016-2021)

Table 76. Global Cell and Gene Therapy Manufacturing QC Revenue Forecast by Application (2021-2026)

Table 77. North America Cell and Gene Therapy Manufacturing QC Revenue by Type (2016-2021) & (USD Million)

Table 78. North America Cell and Gene Therapy Manufacturing QC Revenue by Type (2021-2026) & (USD Million)

Table 79. North America Cell and Gene Therapy Manufacturing QC Revenue by Application (2016-2021) & (USD Million)

Table 80. North America Cell and Gene Therapy Manufacturing QC Revenue by Application (2021-2026) & (USD Million)

Table 81. North America Cell and Gene Therapy Manufacturing QC Revenue by Country (2016-2021) & (USD Million)

Table 82. North America Cell and Gene Therapy Manufacturing QC Revenue by Country (2021-2026) & (USD Million)

Table 83. Europe Cell and Gene Therapy Manufacturing QC Revenue by Type (2016-2021) & (USD Million)

Table 84. Europe Cell and Gene Therapy Manufacturing QC Revenue by Type (2021-2026) & (USD Million)

Table 85. Europe Cell and Gene Therapy Manufacturing QC Revenue by Application (2016-2021) & (USD Million)

Table 86. Europe Cell and Gene Therapy Manufacturing QC Revenue by Application (2021-2026) & (USD Million)

Table 87. Europe Cell and Gene Therapy Manufacturing QC Revenue by Country (2016-2021) & (USD Million)

Table 88. Europe Cell and Gene Therapy Manufacturing QC Revenue by Country (2021-2026) & (USD Million)

Table 89. Asia-Pacific Cell and Gene Therapy Manufacturing QC Revenue by Type (2016-2021) & (USD Million)

Table 90. Asia-Pacific Cell and Gene Therapy Manufacturing QC Revenue by Type (2021-2026) & (USD Million)

Table 91. Asia-Pacific Cell and Gene Therapy Manufacturing QC Revenue by Application (2016-2021) & (USD Million)

Table 92. Asia-Pacific Cell and Gene Therapy Manufacturing QC Revenue by Application (2021-2026) & (USD Million)

Table 93. Asia-Pacific Cell and Gene Therapy Manufacturing QC Revenue by Region (2016-2021) & (USD Million)

Table 94. Asia-Pacific Cell and Gene Therapy Manufacturing QC Revenue by Region (2021-2026) & (USD Million)

Table 95. South America Cell and Gene Therapy Manufacturing QC Revenue by Type (2016-2021) & (USD Million)

Table 96. South America Cell and Gene Therapy Manufacturing QC Revenue by Type (2021-2026) & (USD Million)

Table 97. South America Cell and Gene Therapy Manufacturing QC Revenue by Application (2016-2021) & (USD Million)

Table 98. South America Cell and Gene Therapy Manufacturing QC Revenue by Application (2021-2026) & (USD Million)

Table 99. South America Cell and Gene Therapy Manufacturing QC Revenue by Country (2016-2021) & (USD Million)

Table 100. South America Cell and Gene Therapy Manufacturing QC Revenue by Country (2021-2026) & (USD Million)

Table 101. Middle East & Africa Cell and Gene Therapy Manufacturing QC Revenue by Type (2016-2021) & (USD Million)

Table 102. Middle East & Africa Cell and Gene Therapy Manufacturing QC Revenue by Type (2021-2026) & (USD Million)

Table 103. Middle East & Africa Cell and Gene Therapy Manufacturing QC Revenue by Application (2016-2021) & (USD Million)

Table 104. Middle East & Africa Cell and Gene Therapy Manufacturing QC Revenue by Application (2021-2026) & (USD Million)

Table 105. Middle East & Africa Cell and Gene Therapy Manufacturing QC Revenue by Country (2016-2021) & (USD Million)

Table 106. Middle East & Africa Cell and Gene Therapy Manufacturing QC Revenue by Country (2021-2026) & (USD Million)

List of Figures

Figure 1. Cell and Gene Therapy Manufacturing QC Picture

Figure 2. Global Cell and Gene Therapy Manufacturing QC Revenue Market Share by Type in 2020

Figure 3. Safety Testing

Figure 4. Purity Testing

Figure 5. Potency Testing

Figure 6. Identity Testing

Figure 7. Stability Testing

Figure 8. Cell and Gene Therapy Manufacturing QC Revenue Market Share by Application in 2020

Figure 9. Precision Therapy Picture

Figure 10. Biological Research Picture

Figure 11. Global Cell and Gene Therapy Manufacturing QC Revenue, (USD Million): 2020 VS 2021 VS 2026

Figure 12. Global Cell and Gene Therapy Manufacturing QC Revenue and Forecast (2016-2026) & (USD Million)

Figure 13. Global Cell and Gene Therapy Manufacturing QC Revenue Market Share by Region (2016-2026)

Figure 14. Global Cell and Gene Therapy Manufacturing QC Revenue Market Share by Region in 2020

Figure 15. North America Cell and Gene Therapy Manufacturing QC Revenue (USD Million) and Growth Rate (2016-2026)

Figure 16. Europe Cell and Gene Therapy Manufacturing QC Revenue (USD Million) and Growth Rate (2016-2026)

Figure 17. Asia-Pacific Cell and Gene Therapy Manufacturing QC Revenue (USD Million) and Growth Rate (2016-2026)

Figure 18. South America Cell and Gene Therapy Manufacturing QC Revenue (USD Million) and Growth Rate (2016-2026)

Figure 19. Middle East and Africa Cell and Gene Therapy Manufacturing QC Revenue (USD Million) and Growth Rate (2016-2026)

Figure 20. Cell and Gene Therapy Manufacturing QC Market Drivers

Figure 21. Cell and Gene Therapy Manufacturing QC Market Restraints

Figure 22. Cell and Gene Therapy Manufacturing QC Market Trends

Figure 23. Bio-Techne Corporation Recent Developments and Future Plans

Figure 24. BioMerieux SA Recent Developments and Future Plans

Figure 25. Catalent, Inc. Recent Developments and Future Plans

Figure 26. Charles River Laboratories International Inc. Recent Developments and Future Plans

Figure 27. Eurofins Scientific SE Recent Developments and Future Plans

Figure 28. F. Hoffmann-La Roche Ltd Recent Developments and Future Plans

Figure 29. Intertek Group plc Recent Developments and Future Plans

Figure 30. Lonza Group AG Recent Developments and Future Plans

Figure 31. Merck KGaA Recent Developments and Future Plans

Figure 32. Sartorius AG Recent Developments and Future Plans

Figure 33. SGS S.A. Recent Developments and Future Plans

Figure 34. Sistemic Scotland Limited Recent Developments and Future Plans

Figure 35. Thermo Fisher Scientific Inc. Recent Developments and Future Plans

Figure 36. Vigene Biosciences, Inc. Recent Developments and Future Plans

Figure 37. WuXi AppTec Recent Developments and Future Plans

Figure 38. Global Cell and Gene Therapy Manufacturing QC Revenue Share by Players in 2020

Figure 39. Cell and Gene Therapy Manufacturing QC Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

Figure 40. Global Top 3 Players Cell and Gene Therapy Manufacturing QC Revenue Market Share in 2020

Figure 41. Global Top 10 Players Cell and Gene Therapy Manufacturing QC Revenue Market Share in 2020

Figure 42. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)

Figure 43. Global Cell and Gene Therapy Manufacturing QC Revenue Share by Type in 2020

Figure 44. Global Cell and Gene Therapy Manufacturing QC Market Share Forecast by Type (2021-2026)

Figure 45. Global Cell and Gene Therapy Manufacturing QC Revenue Share by Application in 2020

Figure 46. Global Cell and Gene Therapy Manufacturing QC Market Share Forecast by Application (2021-2026)

Figure 47. North America Cell and Gene Therapy Manufacturing QC Sales Market Share by Type (2016-2026)

Figure 48. North America Cell and Gene Therapy Manufacturing QC Sales Market Share by Application (2016-2026)

Figure 49. North America Cell and Gene Therapy Manufacturing QC Revenue Market Share by Country (2016-2026)

Figure 50. United States Cell and Gene Therapy Manufacturing QC Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 51. Canada Cell and Gene Therapy Manufacturing QC Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 52. Mexico Cell and Gene Therapy Manufacturing QC Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 53. Europe Cell and Gene Therapy Manufacturing QC Sales Market Share by Type (2016-2026)

Figure 54. Europe Cell and Gene Therapy Manufacturing QC Sales Market Share by Application (2016-2026)

Figure 55. Europe Cell and Gene Therapy Manufacturing QC Revenue Market Share by Country (2016-2026)

Figure 56. Germany Cell and Gene Therapy Manufacturing QC Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 57. France Cell and Gene Therapy Manufacturing QC Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 58. United Kingdom Cell and Gene Therapy Manufacturing QC Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 59. Russia Cell and Gene Therapy Manufacturing QC Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 60. Italy Cell and Gene Therapy Manufacturing QC Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 61. Asia-Pacific Cell and Gene Therapy Manufacturing QC Sales Market Share by Type (2016-2026)

Figure 62. Asia-Pacific Cell and Gene Therapy Manufacturing QC Sales Market Share by Application (2016-2026)

Figure 63. Asia-Pacific Cell and Gene Therapy Manufacturing QC Revenue Market Share by Region (2016-2026)

Figure 64. China Cell and Gene Therapy Manufacturing QC Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 65. Japan Cell and Gene Therapy Manufacturing QC Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 66. South Korea Cell and Gene Therapy Manufacturing QC Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 67. India Cell and Gene Therapy Manufacturing QC Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 68. Southeast Asia Cell and Gene Therapy Manufacturing QC Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 69. Australia Cell and Gene Therapy Manufacturing QC Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 70. South America Cell and Gene Therapy Manufacturing QC Sales Market Share by Type (2016-2026)

Figure 71. South America Cell and Gene Therapy Manufacturing QC Sales Market Share by Application (2016-2026)

Figure 72. South America Cell and Gene Therapy Manufacturing QC Revenue Market Share by Country (2016-2026)

Figure 73. Brazil Cell and Gene Therapy Manufacturing QC Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 74. Argentina Cell and Gene Therapy Manufacturing QC Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 75. Middle East and Africa Cell and Gene Therapy Manufacturing QC Sales Market Share by Type (2016-2026)

Figure 76. Middle East and Africa Cell and Gene Therapy Manufacturing QC Sales Market Share by Application (2016-2026)

Figure 77. Middle East and Africa Cell and Gene Therapy Manufacturing QC Revenue Market Share by Country (2016-2026)

Figure 78. Turkey Cell and Gene Therapy Manufacturing QC Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 79. Saudi Arabia Cell and Gene Therapy Manufacturing QC Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 80. UAE Cell and Gene Therapy Manufacturing QC Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 81. Methodology

Figure 82. Research Process and Data Source